Evaluation and Testing Services for Vaccines and Other Biologics for Infectious Diseases
Past New Requirement Updated
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Solicitation expected
- Not on record
- Estimated value
- $3,000,000 to $7,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Points of contact
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The National Institutes of Health (NIH) is forecasting a new requirement for Evaluation and Testing Services for Vaccines and Other Biologics for Infectious Diseases, classified under the Research and Development in Biotechnology NAICS code 541714. The contract is estimated to be awarded on October 1, 2024, with a focus on scientific research and testing related to infectious disease biologics. The opportunity is not set aside for any specific business category, indicating potential competition from various biotechnology research firms.
The points of contact for this federal contract opportunity include Lisa Wei, Science Program Leader in the NIH Office of the Director, and Sharee Richardson, a Contract Specialist who can be reached at +1 240 669 5116. While specific award values and detailed service quantities are not currently provided, the contract is expected to involve comprehensive evaluation and testing services for vaccine and biologic research. Interested contractors should prepare comprehensive proposals demonstrating expertise in biotechnology research, infectious disease testing, and scientific evaluation methodologies, with potential performance likely to be centered at NIH facilities.
Forecast text
Evaluation and Testing Services for Vaccines and Other Biologics for Infectious Diseases
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast